-
Something wrong with this record ?
Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances
C. Guillou, F. Reniero, J. Lobo Vicente, M. Holland, K. Kolar, H. Chassaigne, S. Tirendi, H. Schepers,
Language English Country Netherlands
Document type Letter
- MeSH
- Biomedical Research methods trends MeSH
- European Union * MeSH
- Humans MeSH
- Intersectoral Collaboration * MeSH
- Substance-Related Disorders epidemiology prevention & control MeSH
- Psychotropic Drugs analysis chemistry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
BACKGROUND: The emergence of psychoactive designer drugs has significantly increased over the last few years. Customs officials are responsible for the control of products entering the European Union (EU) market. This control applies to chemicals in general, pharmaceutical products and medicines. Numerous products imported from non-EU countries, often declared as 'bath salts' or 'fertilizers', contain new psychoactive substance (NPS). REVIEW: These are not necessarily controlled under international law, but may be subject to monitoring in agreement with EU legislation. This situation imposes substantial challenges, for example, for the maintenance of spectral libraries used for their detection by designated laboratories. The chemical identification of new substances, with the use of powerful instrumentation, and the time needed for detailed analysis and interpretation of the results, demands considerable commitment. The EU Joint Research Centre endeavors to provide scientific support to EU Customs laboratories to facilitate rapid identification and characterisation of seized samples. In addition to analysing known NPS, several new chemical entities have also been identified. Frequently, these belong to NPS classes already notified to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) by the European Early- Warning System (EWS). CONCLUSION: The aim of this paper is to discuss the implementation of workflow mechanisms that are in place in order to facilitate the monitoring, communication and management of analytical data. The rapid dissemination of this information between control authorities strives to help protect EU citizens against the health risks posed by harmful substances.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000708
- 003
- CZ-PrNML
- 005
- 20190115115707.0
- 007
- ta
- 008
- 190107s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1389201019666180523122717 $2 doi
- 035 __
- $a (PubMed)29792142
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Guillou, Claude $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy.
- 245 10
- $a Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances / $c C. Guillou, F. Reniero, J. Lobo Vicente, M. Holland, K. Kolar, H. Chassaigne, S. Tirendi, H. Schepers,
- 520 9_
- $a BACKGROUND: The emergence of psychoactive designer drugs has significantly increased over the last few years. Customs officials are responsible for the control of products entering the European Union (EU) market. This control applies to chemicals in general, pharmaceutical products and medicines. Numerous products imported from non-EU countries, often declared as 'bath salts' or 'fertilizers', contain new psychoactive substance (NPS). REVIEW: These are not necessarily controlled under international law, but may be subject to monitoring in agreement with EU legislation. This situation imposes substantial challenges, for example, for the maintenance of spectral libraries used for their detection by designated laboratories. The chemical identification of new substances, with the use of powerful instrumentation, and the time needed for detailed analysis and interpretation of the results, demands considerable commitment. The EU Joint Research Centre endeavors to provide scientific support to EU Customs laboratories to facilitate rapid identification and characterisation of seized samples. In addition to analysing known NPS, several new chemical entities have also been identified. Frequently, these belong to NPS classes already notified to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) by the European Early- Warning System (EWS). CONCLUSION: The aim of this paper is to discuss the implementation of workflow mechanisms that are in place in order to facilitate the monitoring, communication and management of analytical data. The rapid dissemination of this information between control authorities strives to help protect EU citizens against the health risks posed by harmful substances.
- 650 _2
- $a biomedicínský výzkum $x metody $x trendy $7 D035843
- 650 12
- $a Evropská unie $7 D005062
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mezisektorová spolupráce $7 D000070516
- 650 _2
- $a psychotropní léky $x analýza $x chemie $7 D011619
- 650 _2
- $a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $x prevence a kontrola $7 D019966
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Reniero, Fabiano $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy.
- 700 1_
- $a Lobo Vicente, Joana $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy. European Environment Agency, Copenhagen, Denmark. Work Developed Whilst Working for the Joint Research Centre.
- 700 1_
- $a Holland, Margaret $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy.
- 700 1_
- $a Kolar, Kamil $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy. Czech Agriculture and Food Inspection Authority, Brno, The Czech Republic.
- 700 1_
- $a Chassaigne, Hubert $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy.
- 700 1_
- $a Tirendi, Salvatore $u European Commission, Directorate-General Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Ispra (VA), Italy.
- 700 1_
- $a Schepers, Herve $u European Commission, Directorate-General for Taxation and Customs Union (TAXUD) Unit A.4 Brussels, Belgium.
- 773 0_
- $w MED00007892 $t Current pharmaceutical biotechnology $x 1873-4316 $g Roč. 19, č. 2 (2018), s. 91-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29792142 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190115115917 $b ABA008
- 999 __
- $a ok $b bmc $g 1364729 $s 1038831
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 19 $c 2 $d 91-98 $i 1873-4316 $m Current pharmaceutical biotechnology $n Curr Pharm Biotechnol $x MED00007892
- LZP __
- $a Pubmed-20190107
